On August 23, 2022, JD Health issued the 2022 interim results announcement. During the reporting period, JD Health's total income was 20.2 billion yuan, an increase of 48.3 percent over the same period last year, and the net profit under non-International Financial reporting Standards (Non-IFRS) reached 1.21 billion yuan, an increase of 82.0 percent over the same period last year. As of June 30, 2022, the number of annual active users in the past 12 months exceeded 131 million, compared with a net increase of more than 22.7 million.
According to the announcement, JD Health continued to strengthen the construction of omni-channel supply chain system in the first half of the year, further improving the ability and efficiency of supply chain management, through the pharmaceutical health retail business with JD.com Pharmacy as the core, continue to give full play to the effectiveness of the digital social supply chain; on the one hand, provide users with one-stop professional service experience, on the other hand, join hands with pharmaceutical companies and other ecological partners to accelerate the digital transformation of the pharmaceutical and health industry.
Continuously strengthen the capacity of pharmaceutical health omni-channel supply chain
In the first half of 2022, JD Health continuously strengthened the synergy of self-management, online platform and omni-channel business, and comprehensively consolidated the capacity of pharmaceutical and health omni-channel supply chain on the basis of continuously enriching the categories of pharmaceutical and health commodities.
As of June 30,2022, JD Health has used JD Logistics, Inc. 's 20 pharmaceutical warehouses and more than 450non-pharmaceutical warehouses across the country. JD.com Pharmacy's "self-supporting cold chain" capability has covered more than 240cities across the country. JD.com 's offline DTP pharmacy has been expanded to 26 provincial administrative regions across the country, effectively improving cold chain drug types and compliance capabilities, while providing users with a more professional and efficient one-stop experience.
In the first half of 2022, JD Health deepened cooperation with a number of leading pharmaceutical companies at home and abroad, and became an important partner for many pharmaceutical brands to speed up digital operations and carry out digital innovation projects. at the same time, a number of pharmaceutical companies launched new specialties online at JD.com Pharmacy. Among them, the self-operated flagship stores of many pharmaceutical companies, including Novartis AG, BeiGene, Ltd., Lunan Pharmaceutical and Hengrui Pharmaceutical, have also been officially launched to provide professional and efficient one-stop services for more chronically ill patients.
What is noteworthy is that JD Health also cooperated with Tongrentang Technology, Qilu Pharmaceutical and Broad Pharmaceutical to carry out "real world research" projects around the whole life cycle of pharmaceutical products to jointly promote the improvement of clinical research and diagnosis and treatment. As of June 30, 2022, JD Health, together with CRO (contract research organization) and the JD Health Clinical trial patient recruitment Center set up by many pharmaceutical companies, has launched more than 400 phase I-III clinical trial projects under development to speed up new drug research and development and market efficiency.
In the field of health products such as medical devices, nutrition and health care, and traditional nourishment, JD Health continues to focus on the fine and professional needs of consumers, creating diversified and healthy consumption scenarios. During the reporting period, JD Health established strategic cooperation with Tongrentang Health, Tomson Baijian and other global leading companies, and provided them with global marketing solutions. It also cooperated with Rejing Biology, Wantai Biology, Lepu Diagnostics and other domestic enterprises that were approved by COVID-19 antigen self-test products, and became its first online partner.
JD Health also helps cooperative merchants to upgrade their business digitally in all directions. During the 618 period this year, the turnover of more than 400 cooperative merchants doubled compared with the same period last year. "Jingdong Drug Express delivery", an omni-channel service, has joined hands with more than 60,000 merchants to provide full-time and omni-channel convenient services for users in more than 400 cities by jointly building a grid-based operation ecology and a variety of implementation methods.
Constantly polish the experience of one-stop professional service
In the first half of 2022, JD Health focused on improving the ability of professional service, and continuously made new progress in the fields of disease science popularization, single disease management, pharmaceutical care, and so on.
In February 2022, in order to further alleviate the problems faced by patients with rare diseases, on the occasion of the first anniversary of the launch of the care center for rare diseases at JD.com Pharmacy, JD Health officially launched the "all-ecological service strategy for rare diseases" by joining hands with all parties in the industrial chain. work together to build a full ecological service platform for rare diseases We will continue to deepen capacity-building for ecological services in the areas of patient service, new drug marketing, disease diagnosis, doctor training, and charitable assistance.
JD Health is constantly going deep into the group of patients with single disease and ploughing out-of-hospital pharmaceutical services. In May 2022, JD Health comprehensively upgraded JD.com 's single disease care center in four major fields, including doctor-patient communication, doctor free clinic, health science popularization, and health monitoring. Up to now, JD.com Pharmacy has launched 13 single disease care centers, corresponding to more than 24 diseases. Data show that since it was launched more than a year ago, the average number of days per user of care centers such as diabetes and gout in JD.com Pharmacy has increased by 62% on average, and patients' compliance with medication has been significantly improved. The phenomenon of health problems caused by prescription errors, unauthorized withdrawal of drugs, or addition or reduction of drugs has been effectively curbed.
In addition, in order to better guide and help users to use drugs rationally and ensure the safety of drug use among the public, JD Health's long-polished "Pharmacy Clinic" was officially launched in June 2022. By cooperating with licensed pharmacists with clinical pharmaceutical experience, JD Health Pharmaceutical Clinic can provide users with a series of professional online pharmaceutical services, such as drug treatment evaluation, post-diagnosis medication plan adjustment, drug treatment plan follow-up, pharmaceutical knowledge popularization, and so on. by combining individual users and special conditions, help them to solve the problem of post-diagnosis medication outside the hospital.
JD Health said that in the process of continuously deepening the one-stop professional service experience of medicine and health, JD Health pays special attention to building and improving the safety experience of users using drugs in the whole scene. JD Health's full-time team of pharmacists and doctors will complement each other with the advantages of clinical pharmacists in cooperation with offline hospitals, and jointly create a safe, professional and comprehensive drug use service system by means of digital and intelligent technology. we will further strengthen the follow-up management of drug use after diagnosis and the experience of home pharmaceutical care.